Joel Greenblatt Sorrento Therapeutics, Inc. Transaction History

Gotham Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$5.76 - $11.95 $114,785 - $238,139	-19,928 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$6.17 - $18.82 $78,753 - $240,218	-12,764 Reduced 39.04%	19,928 $222,000
Q2 2020 Aug 13, 2020	BUY	$1.73 - $6.76 $56,557 - $220,997	32,692 New	32,692 $205,000
Q3 2018 Nov 14, 2018	SELL	$4.22 - $7.5 $551,904 - $980,872	-130,783 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$4.75 - $8.0 $164,654 - $277,312	-34,664 Reduced 20.95%	130,783 $942,000
Q1 2018 May 15, 2018	BUY	$4.5 - $9.95 $551,587 - $1.22 Million	122,575 Added 285.91%	165,447 $852,000
Q4 2017 Feb 14, 2018	BUY	$1.75 - $3.8 $75,026 - $162,913	42,872	42,872 $163,000

5.51M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.